Osterweis Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$41.2K Hold
117
﹤0.01% 204
2025
Q4
$38.3K Hold
117
﹤0.01% 234
2025
Q3
$33K Hold
117
﹤0.01% 235
2025
Q2
$32.7K Sell
117
-5
-4% -$1.42K ﹤0.01% 238
2025
Q1
$38K Sell
122
-196
-62% -$57.9K ﹤0.01% 158
2024
Q4
$82.9K Hold
318
﹤0.01% 159
2024
Q3
$102K Hold
318
0.01% 156
2024
Q2
$99.4K Hold
318
0.01% 153
2024
Q1
$90.4K Sell
318
-29
-8% -$8.49K 0.01% 154
2023
Q4
$99.9K Hold
347
0.01% 148
2023
Q3
$93.3K Hold
347
0.01% 151
2023
Q2
$77K Sell
347
-30
-8% -$6.96K 0.01% 158
2023
Q1
$91.1K Hold
377
0.01% 155
2022
Q4
$99K Hold
377
0.01% 152
2022
Q3
$85K Buy
+377
New +$91.4K 0.01% 149

Other funds holding AMGN

Osterweis Capital Management's AMGN Position: Q1 2026 in Review

Osterweis Capital Management held its Amgen (AMGN) position steady in Q1 2026 at 117 shares worth $41.2K. The position accounts for ﹤0.01% of the portfolio, ranked #204.

Osterweis Capital Management first reported a position in AMGN in Q3 2022 and has held it in 15 quarters since. The position peaked at $102K in Q3 2024. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Osterweis Capital Management held 117 shares of Amgen worth $41.2K as of Q1 2026.
  • Osterweis Capital Management left its Amgen share count unchanged in Q1 2026.
  • Amgen made up ﹤0.01% of Osterweis Capital Management's portfolio in Q1 2026, its #204 holding.
  • Osterweis Capital Management first reported a position in Amgen in Q3 2022 and has held it in 15 quarters since.
  • Osterweis Capital Management's Amgen position peaked at $102K in Q3 2024.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Osterweis Capital Management's 13F filing for Q1 2026, filed 15 May 2026.